Whalegun
Home

Alkermes ALKS paid Penn Avenue Partners $50K for lobbying in Q3 2023 · Pharmacy, Medicare

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q3 2023
Stock
Alkermes ALKS
Client
Alkermes
Reported
23/10/04

Up 0.0% from last quarter

What else happened in Alkermes around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Alkermes's other lobbying reports

  • Alkermes

    LobbyingAlkermes

    Under $5,000

    Reported 09/15

  • Alkermes

    LobbyingAlkermes

    $60K

    Reported 08/03

  • Alkermes

    LobbyingAlkermes

    $60K

    Reported 07/20

  • Alkermes

    LobbyingAlkermes

    $50K

    Reported 07/20

  • Alkermes

    LobbyingAlkermes

    $930K

    Reported 07/20